scispace - formally typeset
G

Garret A. FitzGerald

Researcher at University of Pennsylvania

Publications -  573
Citations -  64984

Garret A. FitzGerald is an academic researcher from University of Pennsylvania. The author has contributed to research in topics: Prostacyclin & Thromboxane. The author has an hindex of 127, co-authored 547 publications receiving 60448 citations. Previous affiliations of Garret A. FitzGerald include French Institute of Health and Medical Research & Brigham and Women's Hospital.

Papers
More filters
Journal ArticleDOI

Prostaglandin F2alpha (PGF2alpha) and the isoprostane, 8, 12-iso-isoprostane F2alpha-III, induce cardiomyocyte hypertrophy. Differential activation of downstream signaling pathways.

TL;DR: Both PGF2α and 8,12-iso-iPF2α-III induce myocyte hypertrophy via discrete signaling pathways through JNK1 and c-Jun pathways and the hypertrophic effects of these two agonists on cardiomyocytes are additive.
Journal ArticleDOI

The Influence of Pravastatin and Atorvastatin on Markers of Oxidative Stress in Hypercholesterolemic Humans

TL;DR: It is suggested that statin therapy results in variable effects on oxidative stress markers in hypercholesterolemic subjects, and future outcome studies should collectively assess various oxidative markers to define clinical utility.
Journal ArticleDOI

Long-lived enzymatic metabolites of thromboxane B2 in the human circulation.

TL;DR: Combined analysis of short- and long-lived enzymatic metabolites of thromboxane B2 promises to bypass the problem of ex vivo platelet activation and enhance the likelihood of relating a discreet clinical event to an alteration in the biosynthesis of thROMboxane A2 in the human circulation.
Journal ArticleDOI

The Isoprostanes: A Perspective

TL;DR: The isoprostanes are a new class of natural products produced in vivo by a non-enzymatic free-radical-induced peroxidation of polyunsaturated fatty acid that can provide an exclusive and selective index for the oxidant component of several inflammatory and degenerative diseases.